Blueprint Medicines - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $90,172.40 -2.00%
Ethereum $3,109.16 -1.52%
BNB $886.09 -2.66%
Optimism $0.31 -3.50%
Arbitrum $0.21 +0.12%
Solana $132.43 -4.39%
Polygon $0.22 +2.77%
Cosmos $2.22 -1.56%
Avalanche $13.57 -1.66%

Bitcoin $90,172.40 -2.00%
Ethereum $3,109.16 -1.52%
BNB $886.09 -2.66%
Optimism $0.31 -3.50%
Arbitrum $0.21 +0.12%
Solana $132.43 -4.39%
Polygon $0.22 +2.77%
Cosmos $2.22 -1.56%
Avalanche $13.57 -1.66%

Blueprint Medicines

company

Investors

Number of Lead Investors

Number of Investors

4

15

Blueprint Medicines is funded by 15 investors. Partner Fund Management and Eight Roads Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Partner Fund Management	Yes	Series C
Eight Roads Ventures	Yes	Series Unknown
Casdin Capital	-	Series C
Cowen Group	-	Series C
Fidelity Biosciences	-	Series C
Nextech Invest	-	Series C
Perceptive Advisors	-	Series C
RA Capital Management	-	Series C
Redmile Group	-	Series C
Sabby Capital	-	Series C
Tavistock Life Sciences	-	Series C
Third Rock Ventures	-	Series C
Wellington Management	-	Series C
Biotechnology Value Fund	-	Series B
F-Prime Capital	-	Series B